Logo image of GLMD

GALMED PHARMACEUTICALS LTD (GLMD) Stock Price, Quote, News and Overview

NASDAQ:GLMD - Nasdaq - IL0011313900 - Common Stock - Currency: USD

2.7031  +0.15 (+6%)

GLMD Quote, Performance and Key Statistics

GALMED PHARMACEUTICALS LTD

NASDAQ:GLMD (2/21/2025, 8:23:54 PM)

2.7031

+0.15 (+6%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High23.8
52 Week Low2.24
Market Cap4.08M
Shares1.51M
Float1.49M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)04-02 2025-04-02/amc
IPO03-13 2014-03-13


GLMD short term performance overview.The bars show the price performance of GLMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

GLMD long term performance overview.The bars show the price performance of GLMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of GLMD is 2.7031 USD. In the past month the price decreased by -8.06%. In the past year, price decreased by -37.88%.

GALMED PHARMACEUTICALS LTD / GLMD Daily stock chart

GLMD Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About GLMD

Company Profile

GLMD logo image Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Company Info

GALMED PHARMACEUTICALS LTD

16 Tiomkin Street

TEL AVIV-YAFO 6578317 IL

CEO: Allen Baharaff

Employees: 6

Company Website: https://www.galmedpharma.com

Investor Relations: http://galmedpharma.investorroom.com/

Phone: 97236938448

GALMED PHARMACEUTICALS LTD / GLMD FAQ

What is the stock price of GALMED PHARMACEUTICALS LTD today?

The current stock price of GLMD is 2.7031 USD. The price increased by 6% in the last trading session.


What is the ticker symbol for GALMED PHARMACEUTICALS LTD stock?

The exchange symbol of GALMED PHARMACEUTICALS LTD is GLMD and it is listed on the Nasdaq exchange.


On which exchange is GLMD stock listed?

GLMD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for GALMED PHARMACEUTICALS LTD stock?

7 analysts have analysed GLMD and the average price target is 12.24 USD. This implies a price increase of 352.81% is expected in the next year compared to the current price of 2.7031. Check the GALMED PHARMACEUTICALS LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GALMED PHARMACEUTICALS LTD worth?

GALMED PHARMACEUTICALS LTD (GLMD) has a market capitalization of 4.08M USD. This makes GLMD a Nano Cap stock.


How many employees does GALMED PHARMACEUTICALS LTD have?

GALMED PHARMACEUTICALS LTD (GLMD) currently has 6 employees.


What are the support and resistance levels for GALMED PHARMACEUTICALS LTD (GLMD) stock?

GALMED PHARMACEUTICALS LTD (GLMD) has a support level at 2.61 and a resistance level at 2.71. Check the full technical report for a detailed analysis of GLMD support and resistance levels.


Should I buy GALMED PHARMACEUTICALS LTD (GLMD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GALMED PHARMACEUTICALS LTD (GLMD) stock pay dividends?

GLMD does not pay a dividend.


When does GALMED PHARMACEUTICALS LTD (GLMD) report earnings?

GALMED PHARMACEUTICALS LTD (GLMD) will report earnings on 2025-04-02, after the market close.


What is the Price/Earnings (PE) ratio of GALMED PHARMACEUTICALS LTD (GLMD)?

GALMED PHARMACEUTICALS LTD (GLMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-39.12).


What is the Short Interest ratio of GALMED PHARMACEUTICALS LTD (GLMD) stock?

The outstanding short interest for GALMED PHARMACEUTICALS LTD (GLMD) is 0.46% of its float. Check the ownership tab for more information on the GLMD short interest.


GLMD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

GLMD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to GLMD. No worries on liquidiy or solvency for GLMD as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GLMD Financial Highlights

Over the last trailing twelve months GLMD reported a non-GAAP Earnings per Share(EPS) of -39.12. The EPS increased by 68.95% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -30.19%
ROE -34.3%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-878.46%
Sales Q2Q%N/A
EPS 1Y (TTM)68.95%
Revenue 1Y (TTM)N/A

GLMD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to GLMD. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners3.08%
Ins Owners1.29%
Short Float %0.46%
Short Ratio0.2
Analysts
Analysts82.86
Price Target12.24 (352.81%)
EPS Next Y96.64%
Revenue Next YearN/A